
- The Nasdaq Biotech Index has slumped 3.8% since its Aug. 19 peak.
- The US 10-year yield rose nearly half a percentage point over the same period and briefly hit 5.34%, its highest level since 2002.
- The index tracks nearly 250 biotech companies and remains up roughly 25% this year.